Kwality Pharmaceuticals Ltd. (KPL)
Market Closed
11 Aug, 22:00
MSE XNSE Primary MSE ₹
3,392. 15
+261.3
+8.346%
₹
15.11B Market Cap
57.11 P/E Ratio
- Div Yield
29,189 Volume
0 Eps
₹ 3,130.85
Previous Close Want to track KPL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
KPL closed today higher at ₹3,392.15, an increase of 8.346% from yesterday's close, completing a monthly increase of 19.4545% or ₹552.45. Over the past 12 months, KPL stock gained 202.8705%.
KPL is not paying dividends to its shareholders.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Kwality Pharmaceuticals Ltd. has completed 1 stock splits, with the recent split occurring on Oct 11, 2017.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
KPL Chart
People also search for
Kwality Pharmaceuticals Ltd. (KPL) FAQ
What is the stock price today?
The current price is ₹3,392.15.
On which exchange is it traded?
Kwality Pharmaceuticals Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is KPL.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 15.11B.
Has Kwality Pharmaceuticals Ltd. ever had a stock split?
Kwality Pharmaceuticals Ltd. had 1 splits and the recent split was on Oct 11, 2017.
Kwality Pharmaceuticals Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | - CEO | MSE Exchange | INE552U01010 ISIN |
| India Country | 997 Employees | - Last Dividend | - Last Split | - IPO Date |
Kwality Pharmaceuticals Ltd. is a prominent entity in the manufacturing of pharmaceutical formulations in various dosage forms. The company is dedicated to the development and production of a comprehensive range of medications intended for global health needs. Its packed portfolio includes tablets, capsules, injections, syrups, and ointments, addressing therapeutic areas such as cardiovascular health, pain management, gastronomy, and infectious diseases. As a significant player in the pharmaceutical industry, Kwality Pharmaceuticals holds importance for its focus on both domestic and international markets, exporting products to numerous countries worldwide. This engagement in diverse geographies enhances its market relevance and contributes to its growth trajectory. The company’s commitment to quality and compliance with international standards ensures its products meet regulatory requirements across borders. With a robust infrastructure and continuous investment in research and development, Kwality Pharmaceuticals Ltd. is positioned as a key contributor to global healthcare solutions, emphasizing both accessibility and innovation in its offerings.
Contact Information
Address: Village Nagkalan
Phone: 91 85 5882 0862
Website: https://www.kwalitypharma.com
